Leveraging CNS PK & Biodistribution to Inform ASO Dosing

• Interpreting CNS exposure and tissue distribution across species
• Translating preclinical PK into human dose and dosing frequency
• Balancing effective target engagement with safety margins 

Speakers:

Virginia Parks

Director - Clinical Pharmacology

Servier